We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
-1.93%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$34.3B
AUM Growth
+$648M
(+1.9%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
14.31%
Holding
3,015
New
907
Increased
756
Reduced
522
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$260M |
| 2 |
Boeing
BA
|
+$233M |
| 3 |
Arista Networks
ANET
|
+$207M |
| 4 |
Qiagen
QGEN
|
+$193M |
| 5 |
Kenvue
KVUE
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$365M |
| 2 |
AutoZone
AZO
|
+$239M |
| 3 |
Dominion Energy
D
|
+$186M |
| 4 |
Palo Alto Networks
PANW
|
+$185M |
| 5 |
Take-Two Interactive
TTWO
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.23% |
| 2 | Healthcare | 16.69% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Industrials | 8.79% |
| 5 | Energy | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
451
DELISTED
Comerica
CMA
| $16.8M | 0.05% |
405,325
-370,422
| -48% | -$17.6M |
|
452
DuPont de Nemours
DD
$18.6B
| $16.8M | 0.05% |
179,467
-268,726
| -60% | -$25.2M |
|
453
Ally Financial
ALLY
$13.6B
| $16.8M | 0.05% |
629,171
-668,828
| -52% | -$18.7M |
|
454
Caribou Biosciences
CRBU
$152M
| $16.7M | 0.05% |
3,499,833
+3,210,094
| +1,108% | +$19.9M |
|
455
Teva Pharmaceuticals
TEVA
$40.1B
| $16.6M | 0.05% |
1,631,197
+689,739
| +73% | +$6.42M |
|
456
FormFactor
FORM
$9.11B
| $16.6M | 0.05% |
+476,000
| New | +$16M |
|
457
PUT
Procter & Gamble
PG
$340B
| $16.6M | 0.05% |
113,600
+100,000
| +735% | +$15.3M |
|
458
Cigna
CI
$72.3B
| $16.5M | 0.05% |
57,710
-538,411
| -90% | -$154M |
|
459
Pentair
PNR
$10.7B
| $16.5M | 0.05% |
254,489
+243,287
| +2,172% | +$16.4M |
|
460
Treace Medical Concepts
TMCI
$303M
| $16.4M | 0.05% |
1,252,628
-165,916
| -12% | -$3.04M |
|
|
MASI
461
DELISTED
Masimo
MASI
| $16.4M | 0.05% |
186,644
+52,321
| +39% | +$6.09M |
|
462
ArcBest
ARCB
$3.19B
| $16.3M | 0.05% |
160,556
+160,179
| +42,488% | +$16.8M |
|
463
CALL
Chipotle Mexican Grill
CMG
$47B
| $16.3M | 0.05% |
445,000
+360,000
| +424% | +$14M |
|
464
Expro Ltd
XPRO
$1.84B
| $16.3M | 0.05% |
701,394
+500,470
| +249% | +$11.3M |
|
465
Roper Technologies
ROP
$38.5B
| $16.3M | 0.05% |
+33,607
| New | +$16.5M |
|
|
NVMI
466
Nova
NVMI
$12.9B
| $16.1M | 0.05% |
143,500
+40,900
| +40% | +$4.81M |
|
467
Teradyne
TER
$61.9B
| $16.1M | 0.05% |
160,337
-162,713
| -50% | -$17.2M |
|
468
Healthpeak Properties
DOC
$14.7B
| $16.1M | 0.05% |
877,188
+310,509
| +55% | +$6.38M |
|
469
Methanex
MEOH
$4.1B
| $16.1M | 0.05% |
+357,317
| New | +$15.3M |
|
470
Evergy
EVRG
$19B
| $16.1M | 0.05% |
317,233
+59,233
| +23% | +$3.36M |
|
471
Linde
LIN
$222B
| $16.1M | 0.05% |
43,161
-32,791
| -43% | -$12.5M |
|
472
CALL
Ulta Beauty
ULTA
$23.1B
| $16M | 0.05% |
40,000
+30,000
| +300% | +$13.1M |
|
|
RVNC
473
DELISTED
Revance Therapeutics, Inc.
RVNC
| $15.6M | 0.05% |
1,363,168
+686,735
| +102% | +$13.2M |
|
474
PUT
EOG Resources
EOG
$76.1B
| $15.5M | 0.05% |
122,300
+92,200
| +306% | +$11.7M |
|
|
NARI
475
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $15.4M | 0.05% |
235,904
-445,196
| -65% | -$28M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Point72 Asset Management held 3,015 positions worth $34.3B, up 1.9% from $33.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Point72 Asset Management deployed $1.94B of net new capital in Q3 2023, opening 907 new positions and adding to 756 existing holdings. Its largest new stake was Hologic: 1,902,507 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Adobe, an estimated $365M trimmed.
- Point72 Asset Management's largest Q3 2023 buy was Hologic: 1,902,507 shares worth $132M.
- Point72 Asset Management added most to Neurocrine Biosciences in Q3 2023, an estimated $260M increase.
- Point72 Asset Management's biggest Q3 2023 reduction was Adobe, cutting an estimated $365M.
- Point72 Asset Management fully exited Dominion Energy in Q3 2023, selling an estimated $186M.
- Point72 Asset Management's ten largest holdings make up 14% of its $34.3B portfolio in Q3 2023.
- Point72 Asset Management opened 907 new positions and closed 606 in Q3 2023.
- Point72 Asset Management's portfolio value rose 1.9% quarter-over-quarter to $34.3B.
Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.